Indian experience in commercializing institutionally developed biotechnologies

Journal of Scientific and Industrial Research

Volumn 55, Issue 11, 1996, Pages 860-872

  Ghosh, P K ^a  

^a CGO Complex ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; BIOTECHNOLOGY DEVELOPMENT; COMMERCIALISATION; DEVELOPING COUNTRY; GOVERNMENT INTERVENTION; INDUSTRIAL PERFORMANCE; INDUSTRIAL POLICY; POLICY FAILURE; RESEARCH AND DEVELOPMENT; TECHNOLOGY DEVELOPMENT;

INDIA;

EID: 0030438238     PISSN: 00224456     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Annual Reports of the DBT, New Delhi, 1987-88 to 1994-95.
2. Ghosh PK, Biotechnology in India, Aust Biotechnol, 3(4) (1993) pp 214-222.
3. Annual Report of the DBT, New Delhi,1986-87, pp 45-46.
4. Ghosh PK, Indian Scenario on the Medical Diagnostic Business and future Perspective, Hindustan Antibiot Bull, 34(1-2) (1992) pp 32-42.
5. Ghosh PK, A Study of the Diagnostics Market in India: Opportunities and Strengths, in ELISA as Diagnostic Tool: Prospects and Implications, edited by S Vishalakshi and S Mohan (Wiley Eastern Ltd, New Delhi) 1992, pp 32-55.
6. Visalakshi S, R & D and Commercialization Status of Hybridoma Technology in India : An International Comparison, Sci Public Policy, 22(4) (1995) pp 231-238.
7. Mudur G, New Rules Push Researchers Close to Biotech Industry, Science, 269 (1995) pp 297-298.
8. Drugs (Prices Control) Order, 1995, Government of India (Min. of Chem. and Fert., Dept. of Chem. and Petrochem., New Delhi) Gazette of India-Extraordinary, Part II, Sec. 3, Sub. Sec (ii) SO 18(E), dated 6.1.1995.
9. Ghosh PK, Investment Opportunities in Biotechnology-based Indian Pharmaceutical Industry, in Biotechnology Monographs, (Pub Biotech Consortium Indian Ltd, New Delhi), 1(1) (1993) pp 7-21.